-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, AQeEoakPESdiSlkbkCf2DThvL1EBUOmj6q1cMKKmQoVRhQKI87GDfbZBavYfp8gP HrayTEEeoNMkwNDUQfohew== 0001140361-07-020396.txt : 20071025 0001140361-07-020396.hdr.sgml : 20071025 20071025144858 ACCESSION NUMBER: 0001140361-07-020396 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071024 FILED AS OF DATE: 20071025 DATE AS OF CHANGE: 20071025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105741400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DR CITY: FREMONT STATE: CA ZIP: 94555 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Iwanicki David CENTRAL INDEX KEY: 0001322481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 071190607 BUSINESS ADDRESS: BUSINESS PHONE: 510-574-1400 MAIL ADDRESS: STREET 1: 34801 CAMPUS DRIVE CITY: FREMONT STATE: CA ZIP: 94555 4 1 doc1.xml FORM 4 X0202 4 2007-10-24 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001322481 Iwanicki David C/O PDL BIOPHARMA, INC. 34801 CAMPUS DRIVE FREMONT CA 94555 0 1 0 0 VP, Sales & Sales Operations Common Stock 2007-10-24 4 M 0 2187 15.73 A 2187 D Common Stock 2007-10-24 4 S 0 600 20.95 D 1587 D Common Stock 2007-10-24 4 S 0 250 20.96 D 1337 D Common Stock 2007-10-24 4 S 0 400 20.98 D 937 D Common Stock 2007-10-24 4 S 0 437 20.99 D 500 D Common Stock 2007-10-24 4 S 0 250 21.00 D 250 D Common Stock 2007-10-24 4 S 0 250 21.24 D 0 D Employee Stock Option (Right to Buy) 15.73 2007-10-24 4 M 0 2187 0 D 2015-04-08 Common Stock 2187 37197 D Sale was made pursuant to a 10b5-1 plan established by the reporting person. Option vests with respect to 2,187.5 shares per month and 9 shares remained exercisable immediately after this transaction. Only vested options are exercisable /s/ Francis Sarena by Francis Sarena, Attorney- in- Fact for David Iwanicki 2007-10-25 -----END PRIVACY-ENHANCED MESSAGE-----